Literature DB >> 36125736

New-onset eosinophilic granulomatosis with polyangiitis in 2 patients during treatment with IL-5 pathway inhibitors.

Jan Holubar1, Erik Arnaud2, Jonathan Broner2, Yves-Marie Pers3, Alain Proust4, Radjiv Goulabchand2.   

Abstract

Entities:  

Year:  2022        PMID： 36125736     DOI： 10.1007/s12026-022-09317-5

Source DB:  PubMed          Journal:  Immunol Res        ISSN： 0257-277X            Impact factor:   4.505


× No keyword cloud information.
  7 in total

1.  Eosinophilic granulomatosis with polyangiitis evolution during severe eosinophilic asthma treatment with benralizumab.

Authors:  Alojzija Hočevar; Peter Kopač; Žiga Rotar; Martina Plešivčnik Novljan; Sabina Škrgat
Journal:  J Allergy Clin Immunol Pract       Date:  2020-04-15

2.  The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis).

Authors:  A T Masi; G G Hunder; J T Lie; B A Michel; D A Bloch; W P Arend; L H Calabrese; S M Edworthy; A S Fauci; R Y Leavitt
Journal:  Arthritis Rheum       Date:  1990-08

3.  Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis.

Authors:  Michael E Wechsler; Praveen Akuthota; David Jayne; Paneez Khoury; Amy Klion; Carol A Langford; Peter A Merkel; Frank Moosig; Ulrich Specks; Maria C Cid; Raashid Luqmani; Judith Brown; Stephen Mallett; Richard Philipson; Steve W Yancey; Jonathan Steinfeld; Peter F Weller; Gerald J Gleich
Journal:  N Engl J Med       Date:  2017-05-18       Impact factor: 91.245

4.  Benralizumab as a Steroid-Sparing Treatment Option in Eosinophilic Granulomatosis with Polyangiitis.

Authors:  Vamsi P Guntur; Laurie A Manka; Joshua L Denson; Ryan M Dunn; Yeshai T Dollin; Mary Gill; Christena Kolakowski; Matthew J Strand; Michael E Wechsler
Journal:  J Allergy Clin Immunol Pract       Date:  2020-10-14

5.  2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis with Polyangiitis.

Authors:  Peter C Grayson; Cristina Ponte; Ravi Suppiah; Joanna C Robson; Anthea Craven; Andrew Judge; Sara Khalid; Andrew Hutchings; Raashid A Luqmani; Richard A Watts; Peter A Merkel
Journal:  Ann Rheum Dis       Date:  2022-02-02       Impact factor: 27.973

6.  Low-Dose Mepolizumab Effectiveness in Patients Suffering From Eosinophilic Granulomatosis With Polyangiitis.

Authors:  Alessandra Vultaggio; Francesca Nencini; Susanna Bormioli; Emanuele Vivarelli; Laura Dies; Oliviero Rossi; Paola Parronchi; Enrico Maggi; Andrea Matucci
Journal:  Allergy Asthma Immunol Res       Date:  2020-09       Impact factor: 5.764

7.  Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status.

Authors:  Paul A Lyons; James E Peters; Federico Alberici; James Liley; Richard M R Coulson; William Astle; Chiara Baldini; Francesco Bonatti; Maria C Cid; Heather Elding; Giacomo Emmi; Jörg Epplen; Loïc Guillevin; David R W Jayne; Tao Jiang; Iva Gunnarsson; Peter Lamprecht; Stephen Leslie; Mark A Little; Davide Martorana; Frank Moosig; Thomas Neumann; Sophie Ohlsson; Stefanie Quickert; Giuseppe A Ramirez; Barbara Rewerska; Georg Schett; Renato A Sinico; Wojciech Szczeklik; Vladimir Tesar; Damjan Vukcevic; Benjamin Terrier; Richard A Watts; Augusto Vaglio; Julia U Holle; Chris Wallace; Kenneth G C Smith
Journal:  Nat Commun       Date:  2019-11-12       Impact factor: 14.919
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.